Changes in policy processes have impacted policy participants and stimulated the development of new patterns of action and entrepreneurship, but also the emergence of new entrants claiming authority on ‘global’ policy terrains. Privately convened ‘global initiatives’ are proliferating while triggering some conceptual puzzles, blurring the already ill‐defined limits of ‘global processes’. To seize the meanings and implications of ‘going global’, this article explores the empirical scope of such global framing of policy entrepreneurship and why such distinction matters for our understanding of global policy processes. To that end, the case of the Global Commission on Drug Policy (GCDP) is examined.
No takes yet. Share an insight, caveat, or question.
Deborah Alimi (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: